(Q45884566)

17 December 2017

title

Efficacy of ex vivo OPG gene therapy in preventing wear debris induced osteolysis (English)

1 reference

17 December 2017

0 references

1 reference

J Jeffrey Goater

1

1 reference

17 December 2017

Regis J O'Keefe

2

1 reference

17 December 2017

Randy N Rosier

3

1 reference

17 December 2017

J Edward Puzas

4

1 reference

17 December 2017

Edward M Schwarz

5

1 reference

17 December 2017

publication date

1 March 2002

1 reference

17 December 2017

Journal of Orthopaedic Research

published in

1 reference

17 December 2017

volume

20

1 reference

17 December 2017

page(s)

169-173

1 reference

17 December 2017

issue

2

1 reference

17 December 2017

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2801%2900083-3

Effects of interleukin-1 on bone turnover in normal mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2801%2900083-3

Ultrahigh molecular weight polyethylene particles have direct effects on proliferation, differentiation, and local factor production of MG63 osteoblast-like cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2801%2900083-3

The effect of ultra-high molecular weight polyethylene wear debris on MG63 osteosarcoma cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2801%2900083-3

RANK is essential for osteoclast and lymph node development

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2801%2900083-3

Gene therapy for rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2801%2900083-3

Response of three murine macrophage populations to particulate debris: bone resorption in organ cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2801%2900083-3

Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2801%2900083-3

Primary total hip arthroplasty with a cementless porous-coated anatomic total hip prosthesis: 10- to 12-year results of prospective and consecutive series

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2801%2900083-3

Diverse roles of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2801%2900083-3

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2801%2900083-3

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2801%2900083-3

RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2801%2900083-3

Immunological defects in mice with a targeted disruption in Bcl-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2801%2900083-3

Tumor necrosis factor-alpha/nuclear transcription factor-kappaB signaling in periprosthetic osteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2801%2900083-3

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2801%2900083-3

Gene therapy -- promises, problems and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2801%2900083-3

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2801%2900083-3

Interleukin-1 production by activated macrophages surrounding loosened orthopaedic implants: a potential role in osteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2801%2900083-3

7 January 2021

Charnley total hip arthroplasty in patients less than fifty years old. A twenty to twenty-five-year follow-up note.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2801%2900083-3

7 January 2021

Outcome of Charnley total hip replacement across a single health region in England: the results at five years from a regional hip register

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2801%2900083-3

7 January 2021

Studies of the mechanism by which the mechanical failure of polymethylmethacrylate leads to bone resorption

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2801%2900083-3

7 January 2021

Bone formation and bone resorption in failed total joint arthroplasties: histomorphometric analysis with histochemical and immunohistochemical technique

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2801%2900083-3

7 January 2021

NF-kappa B regulates VCAM-1 expression on fibroblast-like synoviocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2801%2900083-3

7 January 2021

Quantitative small-animal surrogate to evaluate drug efficacy in preventing wear debris-induced osteolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2801%2900083-3

7 January 2021

Prosthetic metals interfere with the functions of human osteoblast cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2801%2900083-3

7 January 2021

10.1016/S0736-0266(01)00083-3

Identifiers

DOI

1 reference

17 December 2017

PubMed ID

11918293

1 reference

17 December 2017